Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nittobo (Nitto Boseki Co., Ltd.) is a prominent Japanese industrial conglomerate with a specialized Medical Division that operates as a leader in the in vitro diagnostics (IVD) market. The company focuses on the development, manufacture, and sale of high-quality diagnostic reagents and polyclonal antibodies used in clinical laboratory testing. Its product portfolio includes assays for inflammation markers, serum proteins, and various metabolic indicators, which are utilized globally in automated clinical chemistry analyzers. Nittobo Medical, a key subsidiary, provides essential tools for the diagnosis and monitoring of conditions such as cardiovascular disease, renal dysfunction, and immune system disorders. With a history of innovation spanning over a century, the company leverages its expertise in specialty chemicals to support global healthcare infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nitto Boseki.